Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1606 AL 1620

β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity

Huang L, Deng M, Zhang S, Lu S, Gui X, Fang Y.

Biomed Pharmacother. 2017 Oct;94:666-678. doi: 10.1016/j.biopha.2017.07.125. Epub 2017 Aug 5.

Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report

Norman BP, Lubbe SJ, Tan M, Warren N, Morris HR.

BMC Neurol. 2017 Aug 8;17(1):153. doi: 10.1186/s12883-017-0933-z.

Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach

Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B.

Mayo Clin Proc. 2017 Sep;92(9):1359-1367. doi: 10.1016/j.mayocp.2017.06.010. Epub 2017 Aug 5.

Neurobiological correlates of emotional processing in Parkinson's disease: A systematic review of experimental studies

Moonen AJH, Wijers A, Dujardin K, Leentjens AFG.

J Psychosom Res. 2017 Sep;100:65-76. doi: 10.1016/j.jpsychores.2017.07.009. Epub 2017 Jul 18.

Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration

Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, Zahoor H, Saeed D, Natteru PA, Iyer S, Zaheer A.

Front Cell Neurosci. 2017 Jul 24;11:216. doi: 10.3389/fncel.2017.00216. eCollection 2017.

Transcription Factors: Potential Cell Death Markers in Parkinson's Disease

Wang R, Yang S, Nie T, Zhu G, Feng D, Yang Q.

Neurosci Bull. 2017 Oct;33(5):552-560. doi: 10.1007/s12264-017-0168-4. Epub 2017 Aug 8.

Parkinson's disease: a complex disease revisited

The Lancet.

Lancet. 2017 Jul 29;390(10093):430. doi: 10.1016/S0140-6736(17)31997-9. Epub 2017 Jul 27.

Iron in neurodegenerative disorders: being in the wrong place at the wrong time?

Apostolakis S, Kypraiou AM.

Rev Neurosci. 2017 Nov 27;28(8):893-911. doi: 10.1515/revneuro-2017-0020.

Where we've gone "right" in the Parkinson's community

Pollard EE.

Mov Disord. 2017 Sep;32(9):1316-1318. doi: 10.1002/mds.27076. Epub 2017 Aug 11.

Environment and Neurodegenerative Diseases: An Update on miRNA Role

Ferrante M, Conti GO.

Microrna. 2017 Dec 6;6(3):157-165. doi: 10.2174/2211536606666170811151503.

Biomarker Research in Parkinson's Disease Using Metabolite Profiling

Havelund JF, Heegaard NHH, Færgeman NJK, Gramsbergen JB.

Metabolites. 2017 Aug 11;7(3):42. doi: 10.3390/metabo7030042.

A Guideline for Parkinson's Disease Nurse Specialists, with Recommendations for Clinical Practice

Lennaerts H, Groot M, Rood B, Gilissen K, Tulp H, van Wensen E, Munneke M, van Laar T, Bloem BR.

J Parkinsons Dis. 2017;7(4):749-754. doi: 10.3233/JPD-171195.

Following the fate of endocytosed fibrils

Hasegawa M, Suzuki G.

J Biol Chem. 2017 Aug 11;292(32):13498-13499. doi: 10.1074/jbc.H117.780296.

Genes and Nonmotor Symptoms in Parkinson's Disease

Lim EW, Tan EK.

Int Rev Neurobiol. 2017;133:111-127. doi: 10.1016/bs.irn.2017.05.029. Epub 2017 Jul 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias